Prosecution Insights
Last updated: October 04, 2026

Sensile Medical AG

Technology area: Medical Devices & Mechanical Engineering

2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days

Analysis

Sensile Medical AG is currently processing 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed among 2 distinct examiners, which may lead to different prosecution styles even within the same company portfolio. Both actions are housed within 1 distinct art unit, suggesting that the technical subject matter is closely related. This allows the company to see how different individuals interpret the same technical standards in Medical Devices & Mechanical Engineering.

The busiest examiner, RITCHIE, HADEN MATTHEW, is managing 1 busiest examiner pending action. This constitutes one of the 2 pending office actions currently active. Having 2 distinct examiners within 1 distinct art unit provides a baseline for comparing examiner behavior within a single USPTO division. Practitioners should be prepared to reconcile the 2 pending office actions if the 2 distinct examiners issue conflicting requirements, ensuring that the overall strategy for the Medical Devices & Mechanical Engineering portfolio remains consistent.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (50%)
1
Easy (50%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
§112 only1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RITCHIE, HADEN MATTHEW 1 73.4% +33.8%
DARB, HAMZA A. 1 74.4% +30.9%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18460719 DRUG DELIVERY DEVICE DARB, HAMZA A. 10d overdue
18281784 DRUG DELIVERY DEVICE RITCHIE, HADEN MATTHEW 71d

Top Art Units

Art UnitApps
3783 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18281784 DRUG DELIVERY DEVICE RITCHIE, HADEN MATTHEW 3783 §112 Non-Final OA 71d Pending Sep 13, 2023
18460719 DRUG DELIVERY DEVICE DARB, HAMZA A. 3783 §103 Final Rejection 10d overdue Pending Sep 05, 2023

Managing Sensile Medical AG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month